Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 17/20 | 0.70 |
| ▸ | NMBR | P28336 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30783571 | 0.94 | GRPR (0.65) | GRPRNMBR | |
| SCHEMBL29851846 | 0.94 | GRPR (0.64) | GRPRNMBR | |
| Bombesin SCHEMBL29364598 | 0.93 | GRPR (0.66) | GRPRNMBR | |
| SCHEMBL31738529 | 0.90 | GRPR (0.62) | GRPRNMBR | |
| SCHEMBL29565297 | 0.90 | GRPR (0.68) | GRPRNMBR | |
| SCHEMBL19372503 | 0.87 | GRPR (0.59) | GRPRNMBR | |
| SCHEMBL19365036 | 0.87 | GRPR (0.57) | GRPRNMBR | |
| SCHEMBL16360107 | 0.87 | GRPR (0.58) | GRPRNMBR | |
| SCHEMBL29475770 | 0.87 | GRPR (0.72) | GRPR | |
| SCHEMBL21186302 | 0.86 | GRPR (0.56) | GRPRNMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3518 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094717-A | Targeting ligands for disease-targeting imaging agents and methods of use thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026101236-A1 | PEPTIDES SPECIFICALLY BINDING TO CCR8, AND USE THEREOF | 경희대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| CN-117919452-B | Subcellular organelle active targeting imaging probe and preparation method thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-12 | — | — | CN | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| EP-3532092-B1 | IMMUNOGLOBULINS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2026-04-29 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4728279-A2 | USE OF CUSTOM-DESIGNED PEPTIDES FOR MASS CALIBRATION | DH Technologies Development Pte. Ltd. (SG) | 2026-04-22 | — | — | EP | claimed |
| US-20260097140-A1 | Radiolabelled Compounds | UNIV MELBOURNE (AU) | 2026-04-09 | — | — | US | claimed |
| EP-4712959-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,4,5-TETRAHYDRO-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES AND THE USE THEREOF | Mirum Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4713459-A2 | ANTI-VISTA ANTIBODY RNA OR NUCLEIC ACID CONJUGATES (ARCS OR ANCS), COMPOSITIONS CONTAINING, AND THERAPEUTIC USE THEREOF | LIFORDI IMMUNOTHERAPEUTICS, INC. (US) | 2026-03-25 | — | — | EP | claimed |
| CN-114213010-A | Modified nano-alumina, preparation method thereof, antibacterial ceramic tile and preparation method thereof | 广东粤港澳大湾区国家纳米科技创新研究院 | 2022-03-22 | — | — | CN | claimed |
| EP-2814504-B1 | PROTEASE INHIBITOR-CONTAINING COMPOSITIONS, COMPOSITIONS COMPRISING SAME, AND METHODS FOR PRODUCING AND USING SAME | ORAMED LTD (IL) | 2022-03-16 | — | — | EP | claimed |
| CN-114174339-A | High affinity anti-CD 3 antibodies and methods of making and using the same | 阿迪马布有限责任公司 | 2022-03-11 | — | — | CN | claimed |
| CN-114144437-A | Engineered pH-dependent anti-CD 3 antibodies and methods of making and using the same | 阿迪马布有限责任公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114097947-A | Composition for rapidly increasing feed intake of livestock and preparation method thereof | 广州佳牧生物科技有限公司 | 2022-03-01 | — | — | CN | claimed |
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | claimed |
| EP-3568694-B1 | TARGETED DOXORUBICIN-GOLD NANOCONJUGATES FOR TUMOR THERAPY | UNIV MISSOURI (US) | 2022-02-16 | — | — | EP | claimed |
| CN-114040779-A | Conjugates of cell binding molecules containing branched linkers and cytotoxic agents | 杭州多禧生物科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-114040781-A | Formulation of conjugate of TUBULYSIN derivative and cell binding molecule | 杭州多禧生物科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113967255-A | Wavelength-adjustable BODIPY nano-particles and preparation method and application thereof | 西安交通大学 | 2022-01-25 | — | — | CN | claimed |